Compare Haedal Protocol (HAEDAL) vs Enzyme (MLN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Haedal Protocol vs Enzyme — how do they compare? Haedal Protocol trades at Rp294.53 (market cap Rp133,79M, Rp20,91M 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: Haedal Protocol and Enzyme are close in size by market cap, and Haedal Protocol's supply is capped (454,2M / 1B HAEDAL (46%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Haedal Protocol for 14 Days and Enzyme for 28 Days on average.
| HAEDAL | MLN | |
|---|---|---|
Market Cap | Rp133,79M | Rp134,13M |
Volume (24h) | Rp20,91M | Rp104,56M |
Circulating Supply | 454,2M / 1B HAEDAL (46%) | 3,3M MLN |
Typical Hold Time | 14 Days | 28 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Haedal Protocol currently trades at Rp294.53 with a market cap of Rp133.55M, showing bearish technical signals overall. The asset sits near its pivot point of Rp295, with immediate support at Rp286 and resistance at Rp306. With 46% of the 1M max supply in circulation and average hold time of 14 days, the token displays moderate distribution. No recent protocol updates or major ecosystem developments were identified.
The outlook remains cautious with bearish technical indicators outweighing neutral oscillators. Key opportunities include potential bounce from support levels, while risks include limited liquidity and the dominant bearish trend. Investors should monitor for protocol developments and increased trading volume to confirm any trend reversal.
Enzyme (MLN) currently holds a market capitalization of Rp134.13 million with a circulating supply of 3.3 million tokens. The asset shows moderate market activity with a hold time of 28 days indicating average investor retention. Recent market data suggests stable trading patterns within the decentralized finance ecosystem, though specific price action requires current exchange verification.
Outlook remains cautiously neutral given limited recent protocol updates. Key opportunities include potential DeFi ecosystem growth integration, while risks center on typical crypto volatility and regulatory uncertainty. Investors should monitor on-chain activity and exchange liquidity for clearer directional signals.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Haedal Protocol
Haedal is a leading liquid staking protocol built specifically on the Sui blockchain. It provides a reliable infrastructure that enables users to stake their SUI and Walrus tokens with validators, allowing them to earn ongoing consensus rewards. Additionally, users can unlock liquidity in the form of liquid staking tokens (LST), which can be utilized across decentralized finance (DeFi) applications. Haedal's goal is to become the primary platform for staking and earning within the Sui ecosystem.
Read more on HAEDAL →About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →
